VasoCorp Announces Completion of Phase I Clinical Trial on Nerve Support Formula "NeuropAWAY®" as a Dietary Supplement for Occasional Nerve Discomfort

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

VasoCorp, a Georgia for-profit corporation, on a mission to change the standard of care for those suffering from neuropathic discomfort by proving the efficacy of a dietary supplement formula, announced today the results from their Phase I clinical trial .

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, April 11, 2023
Information
Tags: 
Other Health, Research, General Health, Pharmaceutical, Consumer, Clinical Trials, Science, Biotechnology, Seniors, Vitamins, Supplements, Health, Diabetes, Ageing, Quality of life, Eye, Ernst & Young Entrepreneur of the Year Award, Kidney, Small business, Pharmaceutical industry, Dietary supplement
Geotags: 
GEORGIA, UNITED STATES, NORTH AMERICA, INDIA
⚠ generated by AI ↴
Organisation: 
VASOCORP, VEDIC LIFE SCIENCES
Summary
Key Points: 
  • VasoCorp, a Georgia for-profit corporation, on a mission to change the standard of care for those suffering from neuropathic discomfort by proving the efficacy of a dietary supplement formula, announced today the results from their Phase I clinical trial .
  • The trial was authored by William Cross, President and Founder of VasoCorp, and Dr. Shalini` Srivastava, Director, Vedic Life Sciences, Mumbai, India.
  • The primary objective of the study was to evaluate the effects of a dietary Nerve Support Formula on diabetic neuropathic pain.
  • Mr. Cross has recently updated VasoCorp's portfolio of products with similar novel formulas that support Kidney and Eye health.


VasoCorp, a Georgia for-profit corporation, on a mission to change the standard of care for those suffering from neuropathic discomfort by proving the efficacy of a dietary supplement formula, announced today the results from their Phase I clinical trial. VasoCorp is making life better for those in need of an alternative solution to the prescription drugs that are now used to deal with this condition.

The trial was authored by William Cross, President and Founder of VasoCorp, and Dr. Shalini` Srivastava, Director, Vedic Life Sciences, Mumbai, India. Mr. Cross has a record of research on innovative ideas and basic science discoveries. In 2017, Mr. Cross was awarded Young Entrepreneur of the Year by the U.S. Small Business Administration's Georgia District Office who acknowledge that his "efforts...have helped thousands of people ease their debilitating pain."

The study was conducted under supervision of Dr. Shalini` Srivastava, Vedic Life Sciences, Mumbai, India. The primary objective of the study was to evaluate the effects of a dietary Nerve Support Formula on diabetic neuropathic pain. The results of the study were significant and could have profound, life-changing impacts on the health and wellness of those suffering from nerve discomfort.

The trial was funded by VasoCorp. "Our funding strategy is laser-focused on addressing areas of unmet need for maintaining nerve health in the aging population. The study results have huge potential to dial back the focus on prescription drugs, providing new options and a better quality of life," said Mr. Cross, VasoCorp Founder and President.

Mr. Cross has recently updated VasoCorp's portfolio of products with similar novel formulas that support Kidney and Eye health.

About VasoCorp: VasoCorp is a vitamin supplement company founded in 2016. VasoCorp’s NeuropAWAY® Brand products are focused on the diabetes health market, the aging population, and the health and wellness market. VasoCorp’s patented and patent pending formulas offer a new approach to managing occasional nerve aches, and an alternative to opioids.

About Vedic Life Sciences: Vedic Lifesciences is a contract research organization (CRO), that has completed more than 400 clinical and preclinical studies in compliance with international regulations. Vedic Lifesciences is among the few GCP-compliant CROs that are fully aligned with the FDA and FTC standards for human studies.

Copyright: 
Copyright Business Wire 2023